DiAGSure® ARI Panel (Priority 1)

Intent to use:
The DiAGSure® ARI Panel (Priority 1 Pathogens) is a multiplex real-time PCR assay designed for the simultaneous detection of seven high-priority respiratory pathogens responsible for acute respiratory infections (ARI): Influenza A, Influenza B, H1N1pdm09, H3N2, RSV-A/B, Human Adenovirus, and SARS-CoV-2 (COVID-19). These viruses contribute significantly to respiratory illness burdens worldwide and often present with overlapping clinical symptoms such as fever, cough, and breathlessness, complicating timely and accurate diagnosis. This panel enables early identification of the exact pathogen directly from respiratory specimens, supporting rapid clinical decision-making and outbreak control. With high sensitivity and specificity, it is ideal for both routine diagnosis and public health surveillance. The panel is particularly useful in high-risk settings such as hospitals, ICUs, and during seasonal surges or pandemics. It streamlines workflow, reduces diagnostic delays, and improves patient management and infection control outcomes.

Key Specifications:
Simultaneous detection of Influenza A, Influenza B, H1N1pdm09, H3N2, RSV-A/B, SARS-CoV-2 (COVID-19), and Human Adenovirus in a single multiplex PCR assay.
 Enables rapid and accurate diagnosis of acute respiratory infections with overlapping clinical symptoms.
 High sensitivity and specificity, ensuring reliable detection even in early or low-viral-load infections.
 Reduces diagnostic turnaround time, supporting timely clinical decision-making and isolation strategies.
 Compatible with major real-time PCR platforms, ideal for hospital labs, emergency units, ICUs, and outbreak surveillance.

Sample types:
Oropharyngeal/ Nasopharyngeal Swabs in VTM, BAL, Sputum.

Product information: